- Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors
Synnøve Nymark Aasen et al, 2019, International Journal of Molecular Sciences CrossRef - Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin
Vittorio Castaldo et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef - Onconase Restores Cytotoxicity in Dabrafenib-Resistant A375 Human Melanoma Cells and Affects Cell Migration, Invasion and Colony Formation Capability
Alice Raineri et al, 2019, International Journal of Molecular Sciences CrossRef - Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications
Monica Marzagalli et al, 2019, Seminars in Cancer Biology CrossRef - Melanoma cells with acquired resistance to vemurafenib have decreased autophagic flux and display enhanced ability to transfer resistance
Celia N. Pérez et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef - Iodinated 4,4’‐Bipyridines with Antiproliferative Activity Against Melanoma Cell Lines
Paola Peluso et al, 2024, ChemMedChem CrossRef - Mechanisms of Resistance to Targeted Therapies in Skin Cancers
Anna M. Czarnecka et al, 2021, New Therapies in Advanced Cutaneous Malignancies CrossRef - POU5F1B is responsible for the acquired resistance to dabrafenib in papillary thyroid cancer cells with the BRAF V600E mutation
Jun Li et al, 2024, Endocrine CrossRef - Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma
Zili Zhai et al, 2020, Cancers CrossRef - Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment
Ewelina Dratkiewicz et al, 2019, International Journal of Molecular Sciences CrossRef - Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells
Hillary H. Le et al, 2021, EBioMedicine CrossRef - Chloroacridine derivatives as potential anticancer agents which may act as tricarboxylic acid cycle enzyme inhibitors
Miroslawa Cichorek et al, 2020, Biomedicine & Pharmacotherapy CrossRef - miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK
Vladimir Bezrookove et al, 2024, Journal of Translational Medicine CrossRef - Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified in Clinical and Preclinical Studies
Stephen A. Luebker et al, 2019, Frontiers in Oncology CrossRef - Antiproliferative activity of vanadium compounds: effects on the major malignant melanoma molecular pathways
Marina Pisano et al, 2019, Metallomics CrossRef - Reactive Oxygen Species Regulation of Chemoresistance and Metastatic Capacity of Melanoma: Role of the Cancer Stem Cell Marker CD271
Francesca Beretti et al, 2023, Biomedicines CrossRef - CCT196969 effectively inhibits growth and survival of melanoma brain metastasis cells
Agathe Reigstad et al, 2022, PLOS ONE CrossRef - Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies
Patrizia Limonta et al, 2024, Cancers CrossRef - Allgemeines
Lucie Heinzerling et al, 2019, Medikamentöse Tumortherapie in der Dermato-Onkologie CrossRef - Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review
Ilaria Proietti et al, 2020, Cancers CrossRef - The miRNAs Role in Melanoma and in Its Resistance to Therapy
Francesca Varrone et al, 2020, International Journal of Molecular Sciences CrossRef - Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment
Nazila Fathi Maroufi et al, 2020, Pathology - Research and Practice CrossRef - Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR Expression
Eszter Molnár et al, 2019, International Journal of Molecular Sciences CrossRef - Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma
Shujing Liu et al, 2017, Oncotarget CrossRef - Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
Marie Angèle Cucci et al, 2023, Antioxidants CrossRef